Reduction in spasticity, neuropathic pain, and neuropathic pain of other etiologies.
Link: Sativex: Clinical Efficacy And Tolerability In The Treatment Of Symptoms Of Multiple Sclerosis And Neuropathic Pain
Year: 2006
DOI: 10.1517/14656566.7.5.607
Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.
Sativex as an oromucosal spray; each spray delivers 2.7 mg THC and 2.5 mg CBD. Average use in this study was 22–32 mg/day THC and 20–30 mg/day CBD.